Table 1.

Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2–Positive Participants From the Epidemiology, Immunology, and Clinical Characteristics of Pandemic Infectious Diseases (EPICC) Cohort Study Included in the Evaluation of FLU-PRO Plus

Characteristic Total (N=226)
Age group, y
 <1810 (4.4)
 18–44140 (61.9)
 45–6456 (24.8)
 ≥6520 (8.8)
Sex
 Female86 (38.1)
 Male139 (61.5)
 Missing1 (0.4)
Military status
 Active duty112 (49.6)
 Dependent66 (29.2)
 Retired military48 (21.2)
Outpatients195 (86.3)
Days post–symptom onset on day 1 of FLU-PRO/FLU-PRO Plus
 Median (IQR)6 (4.25–7)
 Range1–7
Symptom severity on day 1
 None57 (25.2)
 Mild91 (40.3)
 Moderate63 (27.9)
 Severe11 (4.9)
 Very severe4 (1.8)
Interference with daily activities on day 1
 Not at all74 (32.7)
 A little bit42 (18.6)
 Somewhat39 (17.3)
 Quite a bit43 (19.0)
 Very much28 (12.4)
Rating of physical health on day 1
 Poor23 (10.2)
 Fair87 (38.5)
 Good82 (36.3)
 Very good27 (11.9)
 Excellent7 (3.1)
Characteristic Total (N=226)
Age group, y
 <1810 (4.4)
 18–44140 (61.9)
 45–6456 (24.8)
 ≥6520 (8.8)
Sex
 Female86 (38.1)
 Male139 (61.5)
 Missing1 (0.4)
Military status
 Active duty112 (49.6)
 Dependent66 (29.2)
 Retired military48 (21.2)
Outpatients195 (86.3)
Days post–symptom onset on day 1 of FLU-PRO/FLU-PRO Plus
 Median (IQR)6 (4.25–7)
 Range1–7
Symptom severity on day 1
 None57 (25.2)
 Mild91 (40.3)
 Moderate63 (27.9)
 Severe11 (4.9)
 Very severe4 (1.8)
Interference with daily activities on day 1
 Not at all74 (32.7)
 A little bit42 (18.6)
 Somewhat39 (17.3)
 Quite a bit43 (19.0)
 Very much28 (12.4)
Rating of physical health on day 1
 Poor23 (10.2)
 Fair87 (38.5)
 Good82 (36.3)
 Very good27 (11.9)
 Excellent7 (3.1)

Data are presented as No. (%) unless otherwise indicated.

Abbreviation: IQR, interquartile range.

Table 1.

Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2–Positive Participants From the Epidemiology, Immunology, and Clinical Characteristics of Pandemic Infectious Diseases (EPICC) Cohort Study Included in the Evaluation of FLU-PRO Plus

Characteristic Total (N=226)
Age group, y
 <1810 (4.4)
 18–44140 (61.9)
 45–6456 (24.8)
 ≥6520 (8.8)
Sex
 Female86 (38.1)
 Male139 (61.5)
 Missing1 (0.4)
Military status
 Active duty112 (49.6)
 Dependent66 (29.2)
 Retired military48 (21.2)
Outpatients195 (86.3)
Days post–symptom onset on day 1 of FLU-PRO/FLU-PRO Plus
 Median (IQR)6 (4.25–7)
 Range1–7
Symptom severity on day 1
 None57 (25.2)
 Mild91 (40.3)
 Moderate63 (27.9)
 Severe11 (4.9)
 Very severe4 (1.8)
Interference with daily activities on day 1
 Not at all74 (32.7)
 A little bit42 (18.6)
 Somewhat39 (17.3)
 Quite a bit43 (19.0)
 Very much28 (12.4)
Rating of physical health on day 1
 Poor23 (10.2)
 Fair87 (38.5)
 Good82 (36.3)
 Very good27 (11.9)
 Excellent7 (3.1)
Characteristic Total (N=226)
Age group, y
 <1810 (4.4)
 18–44140 (61.9)
 45–6456 (24.8)
 ≥6520 (8.8)
Sex
 Female86 (38.1)
 Male139 (61.5)
 Missing1 (0.4)
Military status
 Active duty112 (49.6)
 Dependent66 (29.2)
 Retired military48 (21.2)
Outpatients195 (86.3)
Days post–symptom onset on day 1 of FLU-PRO/FLU-PRO Plus
 Median (IQR)6 (4.25–7)
 Range1–7
Symptom severity on day 1
 None57 (25.2)
 Mild91 (40.3)
 Moderate63 (27.9)
 Severe11 (4.9)
 Very severe4 (1.8)
Interference with daily activities on day 1
 Not at all74 (32.7)
 A little bit42 (18.6)
 Somewhat39 (17.3)
 Quite a bit43 (19.0)
 Very much28 (12.4)
Rating of physical health on day 1
 Poor23 (10.2)
 Fair87 (38.5)
 Good82 (36.3)
 Very good27 (11.9)
 Excellent7 (3.1)

Data are presented as No. (%) unless otherwise indicated.

Abbreviation: IQR, interquartile range.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close